Sylvie Luce

1.2k total citations
16 papers, 125 citations indexed

About

Sylvie Luce is a scholar working on Oncology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sylvie Luce has authored 16 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Physiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sylvie Luce's work include Nutrition and Health in Aging (6 papers), Frailty in Older Adults (3 papers) and Glioma Diagnosis and Treatment (3 papers). Sylvie Luce is often cited by papers focused on Nutrition and Health in Aging (6 papers), Frailty in Older Adults (3 papers) and Glioma Diagnosis and Treatment (3 papers). Sylvie Luce collaborates with scholars based in Belgium, France and Japan. Sylvie Luce's co-authors include Thierry Pepersack, Sandra De Breucker, Lore Decoster, Bernard Kennès, Koen Milisen, Ruud Van Rijswijk, Abdelbari Baitar, Cindy Kenis, Guy Jérusalem and Jean‐Pierre Lobelle and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neurology and Experimental Gerontology.

In The Last Decade

Sylvie Luce

16 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Luce Belgium 6 53 39 38 37 26 16 125
Gustav Magrinat United States 7 43 0.8× 30 0.8× 54 1.4× 120 3.2× 13 0.5× 10 184
Caroline Mariano Canada 9 69 1.3× 42 1.1× 76 2.0× 107 2.9× 13 0.5× 26 228
Monica Drera Italy 3 101 1.9× 71 1.8× 21 0.6× 74 2.0× 22 0.8× 6 210
Rajiv Panikkar United States 7 47 0.9× 100 2.6× 43 1.1× 97 2.6× 8 0.3× 14 258
Bénédicte Gelas‐Dore France 6 15 0.3× 30 0.8× 21 0.6× 17 0.5× 28 1.1× 9 123
Geoffrey Delmore Switzerland 5 24 0.5× 34 0.9× 26 0.7× 77 2.1× 10 0.4× 8 190
Damien Botsen France 7 50 0.9× 89 2.3× 30 0.8× 74 2.0× 4 0.2× 29 171
Gilles Breysacher France 6 80 1.5× 53 1.4× 86 2.3× 169 4.6× 6 0.2× 17 237
Sushmita Rath India 8 16 0.3× 15 0.4× 40 1.1× 83 2.2× 6 0.2× 25 143
Moto Yaga Japan 4 40 0.8× 87 2.2× 32 0.8× 97 2.6× 6 0.2× 13 160

Countries citing papers authored by Sylvie Luce

Since Specialization
Citations

This map shows the geographic impact of Sylvie Luce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Luce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Luce more than expected).

Fields of papers citing papers by Sylvie Luce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Luce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Luce. The network helps show where Sylvie Luce may publish in the future.

Co-authorship network of co-authors of Sylvie Luce

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Luce. A scholar is included among the top collaborators of Sylvie Luce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Luce. Sylvie Luce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Simonelli, Matteo, Mario Caccese, Delphine Larrieu‐Ciron, et al.. (2023). CTIM-32. A PARALLEL COHORT PHASE 2 STUDY OF REGORAFENIB PLUS NIVOLUMAB FOR RECURRENT OR METASTATIC SOLID TUMORS: RESULTS IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR ANAPLASTIC ASTROCYTOMA (AA). Neuro-Oncology. 25(Supplement_5). v69–v70. 1 indexed citations
2.
Racu, Marie-Lucie, Sylvie Luce, Laetitia Lebrun, et al.. (2022). Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor. Acta Neurochirurgica. 164(3). 737–742. 4 indexed citations
3.
Breucker, Sandra De, Sylvie Luce, Rose Njemini, et al.. (2019). Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study. Experimental Gerontology. 130. 110787–110787. 9 indexed citations
4.
Luce, Sylvie, Serge Goldman, Niloufar Sadeghi, et al.. (2018). Administration précoce de témozolomide après chirurgie chez des patients ayant un glioblastome de mauvais pronostic : étude de faisabilité. Bulletin du Cancer. 105(7-8). 664–670. 2 indexed citations
5.
Decoster, Lore, Chantal Quinten, Cindy Kenis, et al.. (2018). Quality of life (QoL) in older patients (pts) with cancer and prognostic factors for QoL decline.. Journal of Clinical Oncology. 36(15_suppl). 10010–10010. 2 indexed citations
6.
Devriendt, Daniel, Niloufar Sadeghi, Sylvie Luce, et al.. (2017). Management of supratentorial recurrent low-grade glioma: A multidisciplinary experience in 35 adult patients. Oncology Letters. 14(3). 2789–2795. 10 indexed citations
7.
Decoster, Lore, Cindy Kenis, Johan Flamaing, et al.. (2017). Adherence to geriatric assessment (GA)-based recommendations in older patients (pts) with cancer.. Journal of Clinical Oncology. 35(15_suppl). 10010–10010. 1 indexed citations
8.
Breucker, Sandra De, et al.. (2016). Comprehensive geriatric assessment and comorbidities predict survival in geriatric oncology. Acta Clinica Belgica. 71(4). 206–213. 22 indexed citations
9.
Bondue, Benjamin, Christiane Knoop, Isabelle Étienne, et al.. (2016). Stent-in-Stent Technique for the Treatment of Proximal Bronchial Restenosis after Insertion of Metallic Stents: A Report of Two Cases. Case Reports in Pulmonology. 2016. 1–4. 2 indexed citations
10.
Duerinck, Johnny, Paul M. Clément, Frank Bouttens, et al.. (2015). Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma. Journal of Neurology. 262(3). 742–751. 11 indexed citations
11.
Baitar, Abdelbari, Cindy Kenis, Lore Decoster, et al.. (2015). Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study. Journal of Geriatric Oncology. 6(5). 401–410. 39 indexed citations
12.
Kenis, Cindy, Dominique Bron, Yves Libert, et al.. (2011). Usefulness of a systematic geriatric screening in older cancer patients: a multicentric study in Belgium. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 8. 1 indexed citations
13.
Berghmans, Thierry, et al.. (1999). Chemotherapy for malignant mesothelioma: a quantitative and qualitative overview of the literature. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 18. 1858. 4 indexed citations
14.
Luce, Sylvie, Marianne Paesmans, Thierry Berghmans, et al.. (1998). [Critical review of the randomized trials assessing the role of adjuvant thoracic irradiation and chemotherapy in the treatment of limited-stage small cell lung cancer].. PubMed. 15(5). 633–41. 15 indexed citations
15.
Berghmans, Thierry, Cathérine Castaigne, Sylvie Luce, et al.. (1998). [Maintenance chemotherapy in the treatment of small cell lung cancer: the advocate's view].. PubMed. 54(3). 119–22. 1 indexed citations
16.
Kerger, Joseph, et al.. (1993). Etoposide oral administré de manière prolongé: un traitement partiellement non cross-résistant avec les dérivés Taxanes dans le cancer de l’ovaire. Bulletin du Cancer. 80(6). 522. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026